Cargando…
GDNF Promotes Survival and Therapeutic Efficacy of Human Adipose-Derived Mesenchymal Stem Cells in a Mouse Model of Parkinson’s Disease
Mesenchymal stem cell (MSC)-based regenerative therapy is regarded as a promising strategy for the treatment of Parkinson’s disease (PD). However, MSC components may exhibit poor intracranial survivability, particularly in the later stages following cell transplantation, limiting their potential cur...
Autores principales: | Sun, Shoujia, Zhang, Quan, Li, Man, Gao, Pan, Huang, Kuan, Beejadhursing, Rajluxmee, Jiang, Wei, Lei, Ting, Zhu, Mingxin, Shu, Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444207/ https://www.ncbi.nlm.nih.gov/pubmed/32292068 http://dx.doi.org/10.1177/0963689720908512 |
Ejemplares similares
-
Management of Caesarean scar pregnancy with or without methotrexate before curettage: human chorionic gonadotropin trends and patient outcomes
por: Wang, Sheng, et al.
Publicado: (2018) -
External fetus in fetu presenting in the second trimester: A case report and literature review
por: Zhu, Ying, et al.
Publicado: (2023) -
The Future of GDNF in Parkinson's Disease
por: Manfredsson, Fredric P., et al.
Publicado: (2020) -
GDNF-Transfected Macrophages Produce Potent Neuroprotective Effects in Parkinson's Disease Mouse Model
por: Zhao, Yuling, et al.
Publicado: (2014) -
Stress-Induced Executive Dysfunction in GDNF-Deficient Mice, A Mouse Model of Parkinsonism
por: Buhusi, Mona, et al.
Publicado: (2016)